RFS Pharma, LLC is a clinical-trial stage pharmaceutical company that specializes in antiviral therapies and cancer. With products currently under development to treat HIV and hepatitis, the company will depend upon the expertise of its founder, Raymond F. Schinazi, Ph.D., D.Sc. (Hon.), and its other talented scientists to rapidly bring new therapies to market.